AXQ Capital LP purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 14,803 shares of the medical research company's stock, valued at approximately $2,014,000. Agilent Technologies comprises about 0.5% of AXQ Capital LP's portfolio, making the stock its 27th biggest holding.
A number of other institutional investors have also bought and sold shares of the company. Bridgefront Capital LLC bought a new position in shares of Agilent Technologies during the 3rd quarter worth about $1,323,000. Wellington Management Group LLP raised its holdings in shares of Agilent Technologies by 4.8% in the 3rd quarter. Wellington Management Group LLP now owns 9,380,521 shares of the medical research company's stock worth $1,203,990,000 after acquiring an additional 433,342 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Agilent Technologies by 3.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company's stock worth $78,026,000 after acquiring an additional 22,498 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company's stock worth $82,712,000 after acquiring an additional 24,687 shares during the last quarter. Finally, Champlain Investment Partners LLC raised its holdings in shares of Agilent Technologies by 33.3% in the 3rd quarter. Champlain Investment Partners LLC now owns 895,770 shares of the medical research company's stock worth $114,972,000 after acquiring an additional 223,750 shares during the last quarter.
Agilent Technologies Stock Up 0.4%
Agilent Technologies stock opened at $136.08 on Tuesday. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $160.27. The firm has a market capitalization of $38.46 billion, a price-to-earnings ratio of 27.33, a P/E/G ratio of 2.77 and a beta of 1.26. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The firm has a 50 day simple moving average of $116.42 and a 200 day simple moving average of $128.54.
Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating analysts' consensus estimates of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business had revenue of $1.84 billion during the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the business earned $1.31 EPS. Agilent Technologies's revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 5.98 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th will be given a $0.255 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies's payout ratio is presently 20.48%.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on A. Wells Fargo & Company lowered their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Thursday, May 28th. Robert W. Baird increased their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research note on Tuesday, May 26th. UBS Group decreased their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research note on Thursday, February 26th. TD Cowen increased their price objective on shares of Agilent Technologies from $147.00 to $155.00 and gave the company a "buy" rating in a research note on Thursday, May 28th. Finally, Royal Bank Of Canada began coverage on shares of Agilent Technologies in a research note on Wednesday, May 27th. They issued an "outperform" rating and a $153.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, twelve have given a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Buy" and an average target price of $162.79.
Get Our Latest Stock Analysis on Agilent Technologies
Agilent Technologies Company Profile
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.